Physician

Heather Elizabeth Holden, MD

According to 2025 Medicare claims, Heather Holden, MD (NPI: 1023296670) practices rheumatology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is ARTHRITIS AND OSTEOPOROSIS CONSULTANTS OF THE CAROLINAS PA (NPI: 1801843925; TIN: 562202409) and primary practice location at 28277-3416. Holden is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Holden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 505 traditional Medicare patients, billed 99,119 HCPCS/CPT codes, and received $1,282,983 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,368 prescription claims across 360 beneficiaries totaling $1,831,279 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 72 records totaling $1,526. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,151,966 and ending at $1,831,279. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	287	26,132	$861,009
2016	321	30,600	$986,984
2017	328	45,689	$1,073,083
2018	369	37,870	$1,023,293
2019	107	305	$19,162
2020	158	9,856	$157,496
2021	159	10,351	$172,644
2022	420	45,811	$820,970
2023	487	95,647	$1,326,604
2024	505	99,119	$1,282,983

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	333	3,084	$1,151,966
2016	383	3,466	$1,865,334
2017	411	3,166	$2,026,100
2018	446	3,160	$2,358,407
2019	191	1,099	$660,265
2020	222	1,640	$1,015,378
2021	261	2,043	$1,606,137
2022	300	2,037	$1,482,325
2023	355	2,283	$1,486,175
2024	360	2,368	$1,831,279

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	197	341	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	242	415	$86
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	108	338	$51
J0897	Injection, denosumab, 1 mg	78	6,120	$21
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	223	356	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	26	728	$282,519
Cosentyx Sensoready Pen	Secukinumab	18	504	$161,815
Xeljanz Xr	Tofacitinib Citrate	26	780	$147,184
Cosentyx Unoready Pen	Secukinumab	11	308	$141,412
Orencia	Abatacept	15	700	$136,180

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	72	$1,526	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Heather Elizabeth Holden, MD?

Tedicare shows public-source Medicare data for Heather Elizabeth Holden, MD (NPI 1023296670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Heather Elizabeth Holden, MD have ACO affiliation data?

Heather Elizabeth Holden, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Heather Elizabeth Holden, MD?

Heather Elizabeth Holden, MD is linked to ARTHRITIS AND OSTEOPOROSIS CONSULTANTS OF THE CAROLINAS PA (billing NPI 1801843925) in the available physician profile data.

Does Heather Elizabeth Holden, MD have Open Payments data?

Heather Elizabeth Holden, MD has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.